Philanthropic support plays a vital role in enabling countries to build stronger health systems and advance towards health equity. From vaccine equity and pandemic preparedness to primary health care, the contributions of philanthropic partners help drive progress across WHO’s key priorities. The importance of philanthropic support was underscored by Dr Tedros Adhanom Ghebreyesus, WHO Director-General, in his recent remarks to the Philanthropy Asia Summit, held in Singapore on 5–7 May 2025. In his remarks, he expressed his appreciation to the Temasek Foundation and the Philanthropy…
As diagnoses of colorectal, breast, and other cancers continue to climb in people under age 50, researchers are trying to understand what’s behind this phenomenon. Is it environmental exposures, genetics, lifestyle? The culprits, they say, remain unclear.
Scientists have developed a test for use during brain cancer surgery that rapidly measures the levels of certain genetic mutations in patients’ tumor samples. The test uses droplet digital polymerase chain reaction technology and produces results within 15 minutes.
A device that measures the “stickiness” of cancer cells in tumor samples may help predict the likelihood of a patient’s cancer metastasizing. Researchers believe the device could eventually help doctors make more informed treatment choices.
FDA has approved the combination of the immunotherapy drugs ipilimumab (Yervoy) and nivolumab (Opdivo) for the initial treatment of people with advanced colorectal cancer whose tumors are classified as MSI-H or dMMR.
In this episode of ECDC: On Air, Maria Keramarou, ECDC's expert in vaccine-preventable diseases, discusses the rising cases of measles in Europe. We explore the highly contagious nature of measles, the importance of vaccination, the resurgence of cases post-COVID, and the challenges of vaccine hesitancy and misinformation. Learn more about the European Immunization Week on our dedicated page here . Find all the information about vaccinations in YOUR language on the European Vaccination Information Portal . For more information about ECDC in general, visit https://ecdc.europa.eu…
Buprenorphine for opioid use disorder (1:30), triptans for acute migraine (5:30), premenstrual syndrome (6:50), pain management for IUD insertion (11:00), liver fibrosis stage in chronic hepatitis C infection (12:30), and cold water immersion for muscle soreness (14:30).
NIA investigators have created a biological clock for mice based on blood measurements. Learn how the clock can help predict differences in aging and how the findings could translate to clinical practice.
A subgroup of mesenchymal stem cells, called high-risk MSCs, appears to fuel the formation of cancerous lesions in the fallopian tubes and the lesions’ transition to ovarian cancer, a study has found.
In this episode, we explore Europe's progress toward the 2030 SDGs with Charlotte Deogan, expert in communicable diseases at ECDC. This episode unpacks SDG Target 3.3, which aims to end the epidemics of HIV/AIDS and tuberculosis, and combat viral hepatitis and sexually transmitted infections by 2030. As ECDC releases its first comprehensive monitoring report on the SDGs, we discuss the EU/EEA's current status and whether we are on track. ECDC’s reports and other work on the SDGs can be found here . For more information about ECDC in general, visit https://ecdc.europa.eu or…
In small trials, personalized treatment vaccines appeared to prevent cancer from returning in patients who had successful surgery to remove their tumors. The treatments, which were created based on intensive analyses of patients’ tumors, appeared to be safe.
Labor management (1:30), acute migraine headache (4:00), tirzepatide for sleep apnea (8:20), options for unintended pregnancy (11:20), artificial intelligence scribes (15:00), and testosterone replacement in men with sexual dysfunction (16:50).
Documented conversations on goals of care are uncommon in AYA patients with advanced cancer. Researchers found that many patients did not have these discussions until the last month of life, and many asked about palliative care.
On the occasion of the World Health Day 2025 dedicated to the theme of Healthier beginnings, hopeful futures, over 100 global WHO offices have organized wide-ranging public advocacy actions in collaboration with Member States, communities, health workers, partner and donor agencies and civil society organizations.
Some cancers come back many years after successful treatment, often as metastatic disease. Researchers believe if and how this happens is heavily influenced by dormant cancer cells and their interaction with the immune system.
Plexin-B1 shapes glial networks around beta-amyloid plaques. An NIA-funded study has found that targeting it may improve plaque clearance and reduce brain inflammation.
A new drug targeting synaptic resilience shows potential in treating Alzheimer’s disease in an NIA-funded study, with early trials indicating safety and possible brain damage reduction. Further research is needed on the drug’s long-term effects.
Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), and Thomas Östros, Vice-President of the European Investment Bank (EIB Global), met at the EIB Group Forum in Luxembourg and signed an agreement for a €10 million grant to strengthen public health across Lebanon. The initiative will re-establish Lebanon's Central Public Health Laboratory and prioritize medication provision and healthcare support to over 50 000 people with chronic diseases like diabetes, cardiovascular issues, and cancer
How can diabetes health care professionals work with cardiologists to treat cardiovascular disease in people with diabetes? Learn more about managing heart disease and heart failure with lifestyle changes and medicines.